中 Contact Us
It can be a significant breakthrough as the second generation of drugs in our developmental pipeline for the treatment of obesity and T2DM.
The financing will help revamp our clinical trials and develop pipeline candidates to produce more innovative medicines for global patients in a much faster speed.
